Quality of life and life expectancy in thalassemic patients with complications.
Gabutti
V
V
Department of Pediatrics, University of Turin, Italy.
Piga
A
A
Sacchetti
L
L
Sandri
A
A
Biginelli
M
M
Saracco
P
P
Ferri
M
M
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D002648:Child; D003676:Deferoxamine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D007011:Hypoparathyroidism / Q000209:etiology; D007037:Hypothyroidism / Q000209:etiology; D007501:Iron / Q000097:blood; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008017:Life Expectancy; D008107:Liver Diseases / Q000209:etiology; D011788:Quality of Life; D013789:Thalassemia / Q000150:complications / Q000401:mortality* / Q000628:therapy
D007502:Iron Chelating Agents; D007501:Iron; D003676:Deferoxamine